Metsera’s IPO Raises $275M to Show How Its Obesity Drugs Can …
2 days ago · With key clinical trial readouts expected this year, the company took its story to investors through an IPO. Metsera initially planned to offer more than 17.1 million shares …
Metsera, Inc. Prices Initial Public Offering at $18.00 per Share ...
4 days ago · Metsera, Inc. prices its IPO at $18 per share, raising approximately $275 million to fund obesity treatments. Quiver AI Summary. Metsera, Inc., a clinical-stage biotechnology …
Obesity-drug maker Metsera posts largest gain as IPOs
3 days ago · Metsera's IPO is richest among the Friday debutantes New York-based Metsera priced 15.28 million shares at $18 apiece to raise $275 million as the largest of the IPOs …
Metsera, Maze secure combined $415 million in IPOs
5 days ago · The offerings reflect an increase in IPO activity that could continue, as four other biotechs recently outlined plans to go public. ... Metsera and Maze Therapeutics are the …
Metsera, Maze go public with IPOs of $275M, $113M
3 days ago · Metsera eyes $289M IPO to fund phase 3 weight loss trial. Meanwhile, Maze’s final share price fell squarely in the middle of the $15-$17 range it set out recently, while it raised …
Weight-loss drug developer Metsera raises $275 million in US IPO
4 days ago · New York City-based Metsera sold 15.28 million shares above its targeted range at $18 apiece. The company had initially marketed 17.19 million shares at a range of $15 to $17 …
Drugmakers Metsera and Maze Raise Combined $415 Million in …
4 days ago · Metsera Inc. raised $275 million in its IPO, selling 15.3 million shares for $18 each, according to a statement Bloomberg Terminal It had offered 17.2 million shares for $15 to $17 …
Metsera Announces Pricing of Initial Public Offering
4 days ago · In addition, Metsera has granted the underwriters a 30-day option to purchase up to an additional 2,291,666 shares of common stock at the initial public offering price less …
Metsera Readies $275 Million IPO For Obesity Treatments
6 days ago · Metsera intends to raise $275 million in gross proceeds from an IPO of its common stock, offering approximately 17.19 million shares at a proposed midpoint price of $16.00 per …
Weight-loss drug developer Metsera targets up to $1.78 billion ...
Jan 27, 2025 · Metsera, which is developing weight-loss drugs, said on Monday it is seeking a valuation of up to $1.78 billion in its U.S. IPO, aiming to capitalize on Wall Street's insatiable …
- Some results have been removed